Archive · 1 Aug 2025
Reshma Kewalramani: Biotech Leader with $100M+ Fortune
Reshma Kewalramani is a very successful CEO who runs a big company called Vertex Pharmaceuticals.
She is the first woman to lead this kind of company.
She has made a lot of money, with her net worth exceeding $100 million.
Vertex has developed new medicines for diseases, including sickle cell disease.
She has a medical background and has worked at top hospitals.
Because of her accomplishments, she was included in TIME magazine’s list of the most influential people.
Reshma Kewalramani is the CEO of Vertex Pharmaceuticals.
She is the first woman to lead a major publicly traded US biotech company.
Kewalramani's net worth is estimated to be over $100 million.
She has led medical breakthroughs, including FDA approvals.
Kewalramani was named in TIME magazine’s “100 Most Influential People” list.
- Who
- Reshma Kewalramani, CEO of Vertex Pharmaceuticals.
- What
- Reshma Kewalramani's rise as a wealthy and influential CEO.
- When
- As of mid-2025.
- Where
- United States.
- Why
- Due to her leadership and medical breakthroughs.
- Name
- Reshma Kewalramani
- Role
- CEO and President of Vertex Pharmaceuticals
- Net Worth
- Over $100 million
- Company
- Vertex Pharmaceuticals
- Notable Achievement
- FDA approval of CRISPR-based gene editing therapies
- Origin
- Indian-origin